Prognostic models in coronary artery disease: Cox and network approaches

Antonio Mora1, Rosa Sicari2, Lauro Cortigiani3

  • 1Institute of Clinical Physiology , National Research Council , Pisa, Italy ; Laboratory of Integrative Systems Medicine (LISM) , Institute of Clinical Physiology, National Research Council , Pisa, Italy.

Insights

Network inference offers a complementary approach to Cox models for predicting cardiovascular disease risk. This method reveals complex relationships in patient data, improving the identification of prognostic factors for coronary artery disease patients.

Area of Science:

  • Cardiology
  • Computational Biology
  • Network Science

Background:

  • Cardiovascular disease risk prediction commonly uses Cox models.
  • Complex clinical data patterns can limit Cox model performance and interpretation.
  • Complementary methods are needed to enhance prognostic assessments.

Purpose of the Study:

  • To propose network inference as a method to complement Cox models for cardiovascular disease risk.
  • To explore complex relationships between patient variables and adverse events.
  • To identify prognostic factors and predictors of mortality in coronary artery disease.

Main Methods:

  • Utilized a prospective, multicentre observational study dataset of 4313 patients with known or suspected coronary artery disease (CAD).
  • Employed vasodilator stress echocardiography with coronary flow reserve (CFR) evaluation.
  • Designed a mutual information network to analyze relationships between clinical variables and mortality, complementing Cox models.

Main Results:

  • Network inference revealed complementary insights compared to Cox models, highlighting connectivity paths.
  • The approach relaxed constraints of regression analysis, enabling identification of communities and prognostic paths.
  • Demonstrated characteristic prognostic factors in CAD whose complexity warrants exploration beyond traditional Cox analysis.

Conclusions:

  • Network inference provides valuable complementary information for cardiovascular disease risk stratification.
  • This method enhances the understanding of complex relationships in clinical data for improved prognostication.
  • The study advocates for exploring network-based approaches alongside Cox models for comprehensive CAD risk assessment.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
843
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
461
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
110
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
490